LY3522348

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3522348, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3522348 in Healthy Participants [Phase 1]